0,1,2
Table 6.1.1: Definitions of active surveillance and watchful waiting [481],,
,Active surveillance,Watchful waiting
Treatment intent,Curative,Palliative
Follow-up,Pre-defined schedule,Patient-specific
Assessment/markers used,"DRE, PSA, MRI at recruitment,   re-biopsy","Not pre-defined, but dependent   on development of symptoms of   progression"
Life expectancy,> 10 years,< 10 years
Aim,Minimise treatment-related toxicity   without compromising survival,Minimise treatment-related toxicity
Eligible patients,Mostly low-risk patients,Can apply to patients with all stages
